AtriCure: Pay

AtriCure paid its 5 named executives $21.9M in total in FY2025 (Dec). CEO Michael H. Carrel was paid $9.2M of that.

Pay$100 in the stock at the end of FY20 → $71
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

Michael H. CarrelPresident and Chief Executive Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Douglas J. SeithChief Operating Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Angela L. WirickChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Salvatore PriviteraChief Technical Officer
FY2025 (Dec)
FY2024 (Dec)Not disclosed
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
5 years
Justin J. NozneskyChief Marketing and Strategy Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)Not disclosed
FY2022 (Dec)Not disclosed
4 years

CEO pay against the pay peers

In FY2025 (Dec), the median CEO pay of the 8 peers with pay on file was $9.0M. The CEO of AtriCure was paid $9.2M, 3% above the median.

  1. 1Insulet
  2. 2GLAUKOS
  3. 3iRhythm Holdings
  4. 4Alphatec Holdings
  5. 5AtriCure
  6. 6Inspire Medical Systems
  7. 7Staar Surgical
  8. 8Artivion
  9. 9Penumbra
  10. 10Axogen, Inc.Not disclosed
  11. 11HaemoneticsNot disclosed
  12. 12Inari Medical, Inc.Not disclosed
  13. 13LivaNovaNot disclosed
  14. 14Nevro CorpNot disclosed
  15. 15Tactile Systems Technology, Inc.Not disclosed
  16. 16Tandem Diabetes CareNot disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.